Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 446,086
  • Shares Outstanding, K 122,551
  • Annual Sales, $ 21,190 K
  • Annual Income, $ -203,540 K
  • 60-Month Beta 2.66
  • Price/Sales 18.22
  • Price/Cash Flow N/A
  • Price/Book 3.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.35
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.41
  • Prior Year -0.73
  • Growth Rate Est. (year over year) +52.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.63 +40.68%
on 05/29/19
3.78 -2.08%
on 06/17/19
+0.06 (+1.65%)
since 05/17/19
3-Month
2.63 +40.68%
on 05/29/19
6.50 -43.08%
on 03/22/19
+0.95 (+34.55%)
since 03/18/19
52-Week
1.80 +105.56%
on 03/08/19
7.55 -50.99%
on 07/12/18
-3.60 (-49.32%)
since 06/18/18

Most Recent Stories

More News
Sorrento Therapeutics to Present at the JMP Securities Life Sciences Conference in New York (NY)

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announces today that senior management will be presenting in the upcoming JMP Life Sciences Conference in New York City.

SRNE : 3.70 (+1.65%)
Positive Feline Clinical Trial Outcome Motivates Sorrento Therapeutics to Accelerate Human IND Filing of Resiniferatoxin (RTX) for Prolonged Non-Opioid Control of Post-Amputation Neuropathic Pain

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that review of early results from an on-going "declawed cat pain trial" (run by its Ark Animal Health division) prompted management to...

SRNE : 3.70 (+1.65%)
Real Reasons CBD Products are Projected to Outpace Marijuana

Today, many marketers and retailers, seem to think that their brand(s) can become supercharged just by adding two words to their brand(s) name. More awareness. More sales. Significantly increased revenues!...

SRNE : 3.70 (+1.65%)
CRON : 15.71 (-0.88%)
POTND : 0.0200 (+32.45%)
CRON.TO : 21.05 (-1.08%)
LBUY : 0.8125 (-0.91%)
POTN : 0.0738 (-7.75%)
TGOD.TO : 3.34 (+5.03%)
TGODF : 2.4850 (+4.41%)
Scilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger Integration

-- SP-102 pivotal phase 3 trial remains on track for completion in H1 2020

SRNE : 3.70 (+1.65%)
Evolving Regulatory Climate Signals New Potential Step for CBD Products

FinancialBuzz.com News Commentary

SRNE : 3.70 (+1.65%)
ITHUF : 3.3122 (-5.37%)
XXII : 2.03 (-6.45%)
IAN.CN : 4.380 (-6.61%)
NLBS : 0.1910 (-14.62%)
PBIO : 2.5400 (+2.83%)
Sorrento Announces Cannabidiol (CBD) Global Joint Ventures and Commercial Strategic Partnerships

Sorrento Therapeutics, Inc. (Sorrento, Nasdaq: SRNE) announces that it has formed a Chinese joint venture, Shenzhen Yunma Biotechnology Co., Ltd. ("Shenzhen Yunma"), with LifeTech Scientific Co., Ltd....

SRNE : 3.70 (+1.65%)
Flourishing Cannabis Companies Seek to Fill Corporate Roles

As the cannabis industry begins to heat up, companies are aggressively seeking employees to fill positions. Decades ago, the cannabis plant was being reintroduced into states such as California, Oregon,...

OGI : 6.44 (+3.54%)
SRNE : 3.70 (+1.65%)
CWBHF : 12.8900 (+7.94%)
WDDMF : 1.0636 (-5.88%)
WMD.VN : 1.420 (-5.96%)
CWEB.CN : 19.300 (+1.85%)
ZYNE : 13.79 (+2.76%)
OGI.VN : 8.600 (+2.99%)
Options Traders Expect Huge Moves in Sorrento (SRNE) Stock

Investors need to pay close attention to Sorrento (SRNE) stock based on the movements in the options market lately.

SRNE : 3.70 (+1.65%)
Latin American Governments Seek Cannabis Legalization to Aid in War on Drugs

The War on Drugs has ravaging Latin America, causing thousands of deaths each year along with social and political unrest rife throughout the region. Governments poured in large investments towards launching...

ACB : 7.56 (-0.53%)
ACB.TO : 10.14 (-0.20%)
SRNE : 3.70 (+1.65%)
ACBFF : 8.6900 (-12.80%)
PHCEF : 5.0900 (+1.80%)
BBRRF : 0.2930 (-0.81%)
BBM.CN : 0.380 (-5.00%)
PCLO.VN : 6.700 (+0.75%)
KHRN.VN : 2.250 (-5.86%)
KHRNF : 1.6989 (-5.09%)
Watch for Sorrento Therape to Potentially Pullback After Gaining 6.20% Yesterday

Sorrento Therape (NASDAQ:SRNE) traded in a range yesterday that spanned from a low of $3.63 to a high of $3.95. Yesterday, the shares gained 6.2%, which took the trading range above the 3-day high of...

SRNE : 3.70 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade SRNE with:

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

2nd Resistance Point 3.83
1st Resistance Point 3.76
Last Price 3.70
1st Support Level 3.61
2nd Support Level 3.53

See More

52-Week High 7.55
Fibonacci 61.8% 5.35
Fibonacci 50% 4.68
Fibonacci 38.2% 4.00
Last Price 3.70
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar